RemSleep Holdings Business Summary

RemSleep Holdings Inc. (RMSL) is a medical technology company primarily focused on the design, manufacture, and global distribution of proprietary devices for treating obstructive sleep apnea (OSA) and related respiratory conditions. The company generates revenue through the direct sale of its flagship DeltaWave™ CPAP interface, a nasal pillows system engineered to improve patient compliance by addressing common comfort and airflow issues. As of early 2026, RemSleep has transitioned into an aggressive commercialization phase, supported by recent Medicare PDAC coding approval and expanded FDA 510(k) clearance for its DeltaWave portfolio. Its business model leverages a nationwide contracted sales network and enterprise resource planning (ERP) systems to target durable medical equipment (DME) providers, sleep labs, and institutional healthcare markets. Within the competitive landscape, RemSleep operates as a niche innovator challenging established industry giants such as ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare, and Inspire Medical Systems by focusing specifically on the high-failure segment of CPAP therapy non-compliance. Leadership is spearheaded by Founder, CEO, and President Thomas J. Wood, who brings over 30 years of specialized experience in CPAP therapy and medical device development to the firm. Supporting the technical and operational strategy are Jonathan B. Lane, serving as Vice President and Chief Technology Officer, and Jeff Marshall, who oversees the company’s recent infrastructure scaling as Operations Manager. The executive team is characterized by a lean operational structure that relies heavily on a pedigree of respiratory expertise to navigate complex FDA regulatory pathways and international distribution agreements. While the company maintains a small internal headcount, its strategic growth is backed by institutional shareholders including North Star Asset Management Inc. and Providence Wealth Advisors, LLC, reflecting a focused effort to scale the DeltaWave platform across the broader sleep health ecosystem.